| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 智造有限于2016年由MGIHK独资设立。2016年3月3日，华大控股全资子公司MGIHK签署《深圳华大基因医疗设备有限公司章程》，约定设立华大医疗设备（系发行人前身智造有限之曾用名），注册资本为1,000万美元，由MGIHK以货币方式全额认缴。2016年4月8日，深圳市盐田区经济促进局出具《关于设立外资企业深圳华大基因医疗设备有限公司的批复》（深外资盐复[2016]13号），核准MGIHK设立名称为“深圳华大基因医疗设备有限公司”的外资企业，投资总额为1,200万美元，注册资本为1,000万美元。2016年4月11日，深圳市人民政府向华大医疗设备核发《中华人民共和国台港澳侨投资企业批准证书》。2016年4月13日，深圳市市场监督管理局办理了华大医疗设备的工商设立登记。2016年6月8日，华大医疗设备作出《变更决定》，同意公司名称由“深圳华大基因医疗设备有限公司”变更为“深圳华大智造科技有限公司”。2016年6月15日，深圳市人民政府就公司名称变更换发《中华人民共和国台港澳侨投资企业批准证书》，同日，深圳市市场监督管理局为智造有限换发更名后的营业执照。 | ||||||||||||||||||||||||
| Main Business | 生命科学与生物技术领域仪器设备、试剂耗材等相关产品的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 牟峰 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 韦炜 | ||||||||||||||||||||||||
| Solicitors | 北京市嘉源律师事务所 | ||||||||||||||||||||||||
| Auditors | 毕马威华振会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0755-36352505 | ||||||||||||||||||||||||
| Fax No | 0755-36307300 | ||||||||||||||||||||||||
| Website | www.mgi-tech.com | ||||||||||||||||||||||||
| MGI_IR@mgi-tech.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 09/09/2022 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -1.460 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 20.774 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 15.219B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |